Is AMD Stock an All-Time Buy?
Advanced Micro Devices (NASDAQ:AMD) is a high-growth AI stock that…
Sell
32
IXJ Quote, Financials, Valuation and Earnings
Last price:
$86.62
Seasonality move
:
0.44%
Day range:
$86.50 - $87.20
52-week range:
$85.21 - $101.31
Dividend yield:
1.48%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
58.4K
Avg. volume:
185.7K
1-year change:
1.4%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
IXJ
iShares Global Healthcare ETF
|
-- | -- | -- | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | -- | -- | -- | -- |
|
HART
NYLI Healthy Hearts ETF
|
-- | -- | -- | -- | -- |
|
IBB
iShares Biotechnology ETF
|
-- | -- | -- | -- | -- |
|
JDOC
JPMorgan Healthcare Leaders ETF
|
-- | -- | -- | -- | -- |
|
THNR
Amplify Weight Loss Drug & Treatment ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
IXJ
iShares Global Healthcare ETF
|
$87.14 | -- | -- | -- | $0.62 | 1.48% | -- |
|
AGNG
Global X Aging Population ETF
|
$30.75 | -- | -- | -- | $0.10 | 0.74% | -- |
|
HART
NYLI Healthy Hearts ETF
|
$31.18 | -- | -- | -- | $0.06 | 1.19% | -- |
|
IBB
iShares Biotechnology ETF
|
$134.67 | -- | -- | -- | $0.06 | 0.29% | -- |
|
JDOC
JPMorgan Healthcare Leaders ETF
|
$51.65 | -- | -- | -- | $0.33 | 5.45% | -- |
|
THNR
Amplify Weight Loss Drug & Treatment ETF
|
$23.22 | -- | -- | -- | $0.00 | 0% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
IXJ
iShares Global Healthcare ETF
|
-- | 0.894 | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | 1.009 | -- | -- |
|
HART
NYLI Healthy Hearts ETF
|
-- | 0.784 | -- | -- |
|
IBB
iShares Biotechnology ETF
|
-- | 1.446 | -- | -- |
|
JDOC
JPMorgan Healthcare Leaders ETF
|
-- | 0.904 | -- | -- |
|
THNR
Amplify Weight Loss Drug & Treatment ETF
|
-- | 0.000 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
IXJ
iShares Global Healthcare ETF
|
-- | -- | -- | -- | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | -- | -- | -- | -- | -- |
|
HART
NYLI Healthy Hearts ETF
|
-- | -- | -- | -- | -- | -- |
|
IBB
iShares Biotechnology ETF
|
-- | -- | -- | -- | -- | -- |
|
JDOC
JPMorgan Healthcare Leaders ETF
|
-- | -- | -- | -- | -- | -- |
|
THNR
Amplify Weight Loss Drug & Treatment ETF
|
-- | -- | -- | -- | -- | -- |
iShares Global Healthcare ETF vs. Competitors
-
Which has Higher Returns IXJ or AGNG?
Global X Aging Population ETF has a net margin of -- compared to iShares Global Healthcare ETF's net margin of --. iShares Global Healthcare ETF's return on equity of -- beat Global X Aging Population ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IXJiShares Global Healthcare ETF-- -- -- AGNGGlobal X Aging Population ETF-- -- -- -
What do Analysts Say About IXJ or AGNG?
iShares Global Healthcare ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Global X Aging Population ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares Global Healthcare ETF has higher upside potential than Global X Aging Population ETF, analysts believe iShares Global Healthcare ETF is more attractive than Global X Aging Population ETF.
Company Buy Ratings Hold Ratings Sell Ratings IXJiShares Global Healthcare ETF0 0 0 AGNGGlobal X Aging Population ETF0 0 0 -
Is IXJ or AGNG More Risky?
iShares Global Healthcare ETF has a beta of 0.671, which suggesting that the stock is 32.919% less volatile than S&P 500. In comparison Global X Aging Population ETF has a beta of 0.771, suggesting its less volatile than the S&P 500 by 22.927%.
-
Which is a Better Dividend Stock IXJ or AGNG?
iShares Global Healthcare ETF has a quarterly dividend of $0.62 per share corresponding to a yield of 1.48%. Global X Aging Population ETF offers a yield of 0.74% to investors and pays a quarterly dividend of $0.10 per share. iShares Global Healthcare ETF pays -- of its earnings as a dividend. Global X Aging Population ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IXJ or AGNG?
iShares Global Healthcare ETF quarterly revenues are --, which are smaller than Global X Aging Population ETF quarterly revenues of --. iShares Global Healthcare ETF's net income of -- is lower than Global X Aging Population ETF's net income of --. Notably, iShares Global Healthcare ETF's price-to-earnings ratio is -- while Global X Aging Population ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares Global Healthcare ETF is -- versus -- for Global X Aging Population ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IXJiShares Global Healthcare ETF-- -- -- -- AGNGGlobal X Aging Population ETF-- -- -- --
-
Which has Higher Returns IXJ or HART?
NYLI Healthy Hearts ETF has a net margin of -- compared to iShares Global Healthcare ETF's net margin of --. iShares Global Healthcare ETF's return on equity of -- beat NYLI Healthy Hearts ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IXJiShares Global Healthcare ETF-- -- -- HARTNYLI Healthy Hearts ETF-- -- -- -
What do Analysts Say About IXJ or HART?
iShares Global Healthcare ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand NYLI Healthy Hearts ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares Global Healthcare ETF has higher upside potential than NYLI Healthy Hearts ETF, analysts believe iShares Global Healthcare ETF is more attractive than NYLI Healthy Hearts ETF.
Company Buy Ratings Hold Ratings Sell Ratings IXJiShares Global Healthcare ETF0 0 0 HARTNYLI Healthy Hearts ETF0 0 0 -
Is IXJ or HART More Risky?
iShares Global Healthcare ETF has a beta of 0.671, which suggesting that the stock is 32.919% less volatile than S&P 500. In comparison NYLI Healthy Hearts ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock IXJ or HART?
iShares Global Healthcare ETF has a quarterly dividend of $0.62 per share corresponding to a yield of 1.48%. NYLI Healthy Hearts ETF offers a yield of 1.19% to investors and pays a quarterly dividend of $0.06 per share. iShares Global Healthcare ETF pays -- of its earnings as a dividend. NYLI Healthy Hearts ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IXJ or HART?
iShares Global Healthcare ETF quarterly revenues are --, which are smaller than NYLI Healthy Hearts ETF quarterly revenues of --. iShares Global Healthcare ETF's net income of -- is lower than NYLI Healthy Hearts ETF's net income of --. Notably, iShares Global Healthcare ETF's price-to-earnings ratio is -- while NYLI Healthy Hearts ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares Global Healthcare ETF is -- versus -- for NYLI Healthy Hearts ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IXJiShares Global Healthcare ETF-- -- -- -- HARTNYLI Healthy Hearts ETF-- -- -- --
-
Which has Higher Returns IXJ or IBB?
iShares Biotechnology ETF has a net margin of -- compared to iShares Global Healthcare ETF's net margin of --. iShares Global Healthcare ETF's return on equity of -- beat iShares Biotechnology ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IXJiShares Global Healthcare ETF-- -- -- IBBiShares Biotechnology ETF-- -- -- -
What do Analysts Say About IXJ or IBB?
iShares Global Healthcare ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares Biotechnology ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares Global Healthcare ETF has higher upside potential than iShares Biotechnology ETF, analysts believe iShares Global Healthcare ETF is more attractive than iShares Biotechnology ETF.
Company Buy Ratings Hold Ratings Sell Ratings IXJiShares Global Healthcare ETF0 0 0 IBBiShares Biotechnology ETF0 0 0 -
Is IXJ or IBB More Risky?
iShares Global Healthcare ETF has a beta of 0.671, which suggesting that the stock is 32.919% less volatile than S&P 500. In comparison iShares Biotechnology ETF has a beta of 0.740, suggesting its less volatile than the S&P 500 by 26.046%.
-
Which is a Better Dividend Stock IXJ or IBB?
iShares Global Healthcare ETF has a quarterly dividend of $0.62 per share corresponding to a yield of 1.48%. iShares Biotechnology ETF offers a yield of 0.29% to investors and pays a quarterly dividend of $0.06 per share. iShares Global Healthcare ETF pays -- of its earnings as a dividend. iShares Biotechnology ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IXJ or IBB?
iShares Global Healthcare ETF quarterly revenues are --, which are smaller than iShares Biotechnology ETF quarterly revenues of --. iShares Global Healthcare ETF's net income of -- is lower than iShares Biotechnology ETF's net income of --. Notably, iShares Global Healthcare ETF's price-to-earnings ratio is -- while iShares Biotechnology ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares Global Healthcare ETF is -- versus -- for iShares Biotechnology ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IXJiShares Global Healthcare ETF-- -- -- -- IBBiShares Biotechnology ETF-- -- -- --
-
Which has Higher Returns IXJ or JDOC?
JPMorgan Healthcare Leaders ETF has a net margin of -- compared to iShares Global Healthcare ETF's net margin of --. iShares Global Healthcare ETF's return on equity of -- beat JPMorgan Healthcare Leaders ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IXJiShares Global Healthcare ETF-- -- -- JDOCJPMorgan Healthcare Leaders ETF-- -- -- -
What do Analysts Say About IXJ or JDOC?
iShares Global Healthcare ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand JPMorgan Healthcare Leaders ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares Global Healthcare ETF has higher upside potential than JPMorgan Healthcare Leaders ETF, analysts believe iShares Global Healthcare ETF is more attractive than JPMorgan Healthcare Leaders ETF.
Company Buy Ratings Hold Ratings Sell Ratings IXJiShares Global Healthcare ETF0 0 0 JDOCJPMorgan Healthcare Leaders ETF0 0 0 -
Is IXJ or JDOC More Risky?
iShares Global Healthcare ETF has a beta of 0.671, which suggesting that the stock is 32.919% less volatile than S&P 500. In comparison JPMorgan Healthcare Leaders ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock IXJ or JDOC?
iShares Global Healthcare ETF has a quarterly dividend of $0.62 per share corresponding to a yield of 1.48%. JPMorgan Healthcare Leaders ETF offers a yield of 5.45% to investors and pays a quarterly dividend of $0.33 per share. iShares Global Healthcare ETF pays -- of its earnings as a dividend. JPMorgan Healthcare Leaders ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IXJ or JDOC?
iShares Global Healthcare ETF quarterly revenues are --, which are smaller than JPMorgan Healthcare Leaders ETF quarterly revenues of --. iShares Global Healthcare ETF's net income of -- is lower than JPMorgan Healthcare Leaders ETF's net income of --. Notably, iShares Global Healthcare ETF's price-to-earnings ratio is -- while JPMorgan Healthcare Leaders ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares Global Healthcare ETF is -- versus -- for JPMorgan Healthcare Leaders ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IXJiShares Global Healthcare ETF-- -- -- -- JDOCJPMorgan Healthcare Leaders ETF-- -- -- --
-
Which has Higher Returns IXJ or THNR?
Amplify Weight Loss Drug & Treatment ETF has a net margin of -- compared to iShares Global Healthcare ETF's net margin of --. iShares Global Healthcare ETF's return on equity of -- beat Amplify Weight Loss Drug & Treatment ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IXJiShares Global Healthcare ETF-- -- -- THNRAmplify Weight Loss Drug & Treatment ETF-- -- -- -
What do Analysts Say About IXJ or THNR?
iShares Global Healthcare ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Amplify Weight Loss Drug & Treatment ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares Global Healthcare ETF has higher upside potential than Amplify Weight Loss Drug & Treatment ETF, analysts believe iShares Global Healthcare ETF is more attractive than Amplify Weight Loss Drug & Treatment ETF.
Company Buy Ratings Hold Ratings Sell Ratings IXJiShares Global Healthcare ETF0 0 0 THNRAmplify Weight Loss Drug & Treatment ETF0 0 0 -
Is IXJ or THNR More Risky?
iShares Global Healthcare ETF has a beta of 0.671, which suggesting that the stock is 32.919% less volatile than S&P 500. In comparison Amplify Weight Loss Drug & Treatment ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock IXJ or THNR?
iShares Global Healthcare ETF has a quarterly dividend of $0.62 per share corresponding to a yield of 1.48%. Amplify Weight Loss Drug & Treatment ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. iShares Global Healthcare ETF pays -- of its earnings as a dividend. Amplify Weight Loss Drug & Treatment ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IXJ or THNR?
iShares Global Healthcare ETF quarterly revenues are --, which are smaller than Amplify Weight Loss Drug & Treatment ETF quarterly revenues of --. iShares Global Healthcare ETF's net income of -- is lower than Amplify Weight Loss Drug & Treatment ETF's net income of --. Notably, iShares Global Healthcare ETF's price-to-earnings ratio is -- while Amplify Weight Loss Drug & Treatment ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares Global Healthcare ETF is -- versus -- for Amplify Weight Loss Drug & Treatment ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IXJiShares Global Healthcare ETF-- -- -- -- THNRAmplify Weight Loss Drug & Treatment ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
How High Will Airbnb Stock Go?
Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…
Why Is SoundHound AI Stock Up So Much?
Like many companies improving AI technologies and exploring ways to…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 43x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
57
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
64
ARQQ alert for Dec 27
Arqit Quantum [ARQQ] is down 7.48% over the past day.
Buy
64
QMCO alert for Dec 27
Quantum [QMCO] is up 1.11% over the past day.
Buy
65
ALGS alert for Dec 27
Aligos Therapeutics [ALGS] is down 4.61% over the past day.
